New shot shows promise for tough lymphoma cases
NCT ID NCT07226752
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug called epcoritamab (given as a shot under the skin) against standard chemotherapy for people with diffuse large B-cell lymphoma that has come back or stopped responding to treatment. About 72 participants in China will be randomly assigned to get either the new drug or one of two standard chemo regimens. The main goal is to see if epcoritamab helps people live longer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Hospital of Hebei University
Baoding, China
-
Beijing Cancer Hospital
Beijing, China
-
Beijing Tongren Hospital, Capital Medical University
Beijing, China
-
EC of Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, China
-
Guangdong Provincial Peoples Hospital
Guandong, China
-
Guangxi Medical University Affiliated Tumor Hospital
Guangxi, China
-
Henan Cancer Hospital
Zhengzhou, China
-
Hubei Cancer Hospital
Hubei, China
-
Hunan Cancer Hospital
Hunan, China
-
Peking University Third Hospital
Beijing, China
-
Qingdao Central Hospital
Qingdao, China
-
Shanxi Provincial Cancer Hospital
Shanxi, China
-
Shengjing Hospital of China Medical University
Shenyang, China
-
Shenzhen Peoples Hospital
Shenzhen, China
-
The First Affiliated Hospital of Nanchang University
Nanchang, China
-
The First Affiliated Hospital of Soochow University
Suzhou, China
-
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, China
-
The First Hospital of Jilin University
Changchun, China
-
The Second Affiliated Hospital Zhejiang University School of Medicine
Zhenjiang, China
-
The Second Hospital of Dalian Medical University
Dalian, China
-
Tianjin Medical University Cancer Institute and Hospital
Tianjin, China
-
West China Hospital, Sichuan University
Chengdu, China
-
Yantai Yuhuangding Hospital
Yantai, China